Calcium Homeostasis in the Development of Resistant Breast Tumors
- PMID: 37296835
- PMCID: PMC10251880
- DOI: 10.3390/cancers15112872
Calcium Homeostasis in the Development of Resistant Breast Tumors
Abstract
Cancer is one of the main health problems worldwide. Only in 2020, this disease caused more than 19 million new cases and almost 10 million deaths, with breast cancer being the most diagnosed worldwide. Today, despite recent advances in breast cancer treatment, a significant percentage of patients will either not respond to therapy or will eventually experience lethal progressive disease. Recent studies highlighted the involvement of calcium in the proliferation or evasion of apoptosis in breast carcinoma cells. In this review, we provide an overview of intracellular calcium signaling and breast cancer biology. We also discuss the existing knowledge on how altered calcium homeostasis is implicated in breast cancer development, highlighting the potential utility of Ca2+ as a predictive and prognostic biomarker, as well as its potential for the development of new pharmacological treatments to treat the disease.
Keywords: Ca2+ channels; breast cancer; calcium; homeostasis; resistant tumors; targeted therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer.J Cell Physiol. 2018 Aug;233(8):5623-5641. doi: 10.1002/jcp.26277. Epub 2018 Feb 28. J Cell Physiol. 2018. PMID: 29150934 Review.
-
Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.Enzymes. 2018;44:83-101. doi: 10.1016/bs.enz.2018.08.004. Epub 2018 Oct 5. Enzymes. 2018. PMID: 30360816 Review.
-
Subtype specific targeting of calcium signaling in breast cancer.Cell Calcium. 2020 Jan;85:102109. doi: 10.1016/j.ceca.2019.102109. Epub 2019 Nov 12. Cell Calcium. 2020. PMID: 31783287 Free PMC article.
-
Immunotherapies against HER2-Positive Breast Cancer.Cancers (Basel). 2023 Feb 8;15(4):1069. doi: 10.3390/cancers15041069. Cancers (Basel). 2023. PMID: 36831412 Free PMC article. Review.
Cited by
-
CarcSeq detection of lorcaserin-induced clonal expansion of Pik3ca H1047R mutants in rat mammary tissue.Toxicol Sci. 2024 Sep 1;201(1):129-144. doi: 10.1093/toxsci/kfae070. Toxicol Sci. 2024. PMID: 38851877 Free PMC article.
References
-
- Bloom A.P., Jiménez-Andrade J.M., Taylor R.N., Castañeda-Corral G., Kaczmarska M.J., Freeman K.T., Coughlin K.A., Guilardi J.R., Kuskowsik M.A., Mantyh P.W. Breast cancer-induced bone remodeling, skeletal pain and tenderness flare nerve fibers. J. Pain. 2011;12:698–711. doi: 10.1016/j.jpain.2010.12.016. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous